BINA DAILY · 2026-10-17
Today: AI policy and product news, plus the latest in health and medicine.
|
BINA DAILY · 2026-10-17
|
|
AI BRIEF
AI Regulation Tightens on Both Sides of the Atlantic — and the Pacific
FTC subpoenas, state lawsuits, China export bans, Anthropic's draft bill, Meta's open model, and GSA's new AI contract rules.
IN TODAY'S BRIEF
- FTC Issues Sweeping Subpoenas to OpenAI and Anthropic
- Eight States Sue OpenAI Over Child Safety Failures
- Anthropic Circulates a Narrow Draft Safety Bill on Capitol Hill
- China Targets AI Technology Exports With 40-Item Draft List
- GSA Locks Down LLM Use in Federal Contracts
- UK Parliament Opens Formal AI Governance Inquiry
- Meta Releases Muse Spark Open, Its Most Capable Open-Weight Model
Read the full AI brief →
|
|
|
HEALTH ROUNDUP
Alzheimer's Blood Tests Cleared; Measles Peaks at 4,400; EU Backs Pancreatic Drug
Two FDA approvals — Alzheimer's blood tests and a home-use thyroid therapy — plus an EU pancreatic cancer ruling, as US measles tops 4,410 cases.
IN TODAY'S BRIEF
- Wednesday, 15 October: FDA Approves Two Blood Tests for Alzheimer's Disease
- Wednesday, 15 October: Roche Wins FDA Clearance for First At-Home Thyroid Eye Disease Therapy
- Recent: EU Drug Panel Backs Daraxonrasib for Metastatic Pancreatic Cancer
- Thursday, 16 October: US Measles Surge — 4,410 Cases, Six Deaths in Pennsylvania
- Tuesday, 14 October: Cyprus Moves to Close the Innovation-to-Patient Gap in Medicine
- Thursday, 16 October: Hadassah Medical Centre Limassol Formally Inaugurated
Read the full health roundup →
|
